Abstract

Cortical interneurons establish inhibitory microcircuits throughout the neocortex and their dysfunction has been implicated in epilepsy and neuropsychiatric diseases. Developmentally, interneurons migrate from a distal progenitor domain in order to populate the neocortex - a process that occurs at a slower rate in humans than in mice. In this study, we sought to identify factors that regulate the rate of interneuron maturation across the two species. Using embryonic mouse development as a model system, we found that the process of initiating interneuron migration is regulated by blood vessels of the medial ganglionic eminence (MGE), an interneuron progenitor domain. We identified two endothelial cell-derived paracrine factors, SPARC and SerpinE1, that enhance interneuron migration in mouse MGE explants and organotypic cultures. Moreover, pre-treatment of human stem cell-derived interneurons (hSC-interneurons) with SPARC and SerpinE1 prior to transplantation into neonatal mouse cortex enhanced their migration and morphological elaboration in the host cortex. Further, SPARC and SerpinE1-treated hSC-interneurons also exhibited more mature electrophysiological characteristics compared to controls. Overall, our studies suggest a critical role for CNS vasculature in regulating interneuron developmental maturation in both mice and humans.

Data availability

Bulk RNA-seq datasets for HEK293 and HBEC 5i have been uploaded to NCBI GEO under Accession Number: GSE146991

The following data sets were generated

Article and author information

Author details

  1. Matthieu Genestine

    Pathology and cell biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Daisy Ambriz

    Pathology and cell biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Gregg W Crabtree

    Pathology and cell biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Patrick Dummer

    Pathology & Cell Biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Anna Molotkova

    Pathology & Cell Biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Michael Quintero

    Pathology & Cell Biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Angeliki Mela

    Pathology & Cell Biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Saptarshi Biswas

    Pathology & Cell Biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Huijuan Feng

    Systems Biology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Chaolin Zhang

    Department of Systems Biology, Department of Biochemistry and Molecular Biophysics, Center for Motor Neuron Biology and Disease, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8310-7537
  11. Peter Canoll

    Department of Systems Biology, Department of Biochemistry and Molecular Biophysics, Center for Motor Neuron Biology and Disease, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Gunnar Hargus

    Department of Systems Biology, Department of Biochemistry and Molecular Biophysics, Center for Motor Neuron Biology and Disease, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Dritan Agalliu

    Neurology, Pathology and Cell Biology, Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Joseph A Gogos

    Neurology, Pathology and Cell Biology, Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Edmund Au

    Pathology and Cell Biology, Columbia University, New York, United States
    For correspondence
    ea2515@cumc.columbia.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3190-9711

Funding

Whitehall Foundation (2016-12-137)

  • Edmund Au

Irma T. Hirschl Trust

  • Edmund Au

National Institutes of Health (R03MH119443-01)

  • Edmund Au

National Institutes of Health (R01NS117695)

  • Edmund Au

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Joseph G Gleeson, Howard Hughes Medical Institute, The Rockefeller University, United States

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocol (AC-AAAZ6451) of Columbia University .

Human subjects: We obtained fetal tissue samples for research following induced termination of pregnancy for maternal indications. Sample collection followed the policies of the Columbia University Irving Medical Center Institutional Review Board. IRB waiver AAAS5541 was obtained for non-human subjects research, deemed medical waste.

Version history

  1. Received: February 15, 2020
  2. Accepted: April 26, 2021
  3. Accepted Manuscript published: April 27, 2021 (version 1)
  4. Version of Record published: May 5, 2021 (version 2)

Copyright

© 2021, Genestine et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,311
    views
  • 210
    downloads
  • 8
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Matthieu Genestine
  2. Daisy Ambriz
  3. Gregg W Crabtree
  4. Patrick Dummer
  5. Anna Molotkova
  6. Michael Quintero
  7. Angeliki Mela
  8. Saptarshi Biswas
  9. Huijuan Feng
  10. Chaolin Zhang
  11. Peter Canoll
  12. Gunnar Hargus
  13. Dritan Agalliu
  14. Joseph A Gogos
  15. Edmund Au
(2021)
Vascular-derived SPARC and SerpinE1 regulate interneuron tangential migration and maturation
eLife 10:e56063.
https://doi.org/10.7554/eLife.56063

Share this article

https://doi.org/10.7554/eLife.56063

Further reading

    1. Developmental Biology
    Thierry Gilbert, Camille Gorlt ... Andreas Merdes
    Research Article Updated

    Ninein is a centrosome protein that has been implicated in microtubule anchorage and centrosome cohesion. Mutations in the human NINEIN gene have been linked to Seckel syndrome and to a rare form of skeletal dysplasia. However, the role of ninein in skeletal development remains unknown. Here, we describe a ninein knockout mouse with advanced endochondral ossification during embryonic development. Although the long bones maintain a regular size, the absence of ninein delays the formation of the bone marrow cavity in the prenatal tibia. Likewise, intramembranous ossification in the skull is more developed, leading to a premature closure of the interfrontal suture. We demonstrate that ninein is strongly expressed in osteoclasts of control mice, and that its absence reduces the fusion of precursor cells into syncytial osteoclasts, whereas the number of osteoblasts remains unaffected. As a consequence, ninein-deficient osteoclasts have a reduced capacity to resorb bone. At the cellular level, the absence of ninein interferes with centrosomal microtubule organization, reduces centrosome cohesion, and provokes the loss of centrosome clustering in multinucleated mature osteoclasts. We propose that centrosomal ninein is important for osteoclast fusion, to enable a functional balance between bone-forming osteoblasts and bone-resorbing osteoclasts during skeletal development.

    1. Cell Biology
    2. Developmental Biology
    Nicolas Loyer, Elizabeth KJ Hogg ... Jens Januschke
    Research Article

    The generation of distinct cell fates during development depends on asymmetric cell division of progenitor cells. In the central and peripheral nervous system of Drosophila, progenitor cells respectively called neuroblasts or sensory organ precursors use PAR polarity during mitosis to control cell fate determination in their daughter cells. How polarity and the cell cycle are coupled, and how the cell cycle machinery regulates PAR protein function and cell fate determination is poorly understood. Here, we generate an analog sensitive allele of CDK1 and reveal that its partial inhibition weakens but does not abolish apical polarity in embryonic and larval neuroblasts and leads to defects in polarisation of fate determinants. We describe a novel in vivo phosphorylation of Bazooka, the Drosophila homolog of PAR-3, on Serine180, a consensus CDK phosphorylation site. In some tissular contexts, phosphorylation of Serine180 occurs in asymmetrically dividing cells but not in their symmetrically dividing neighbours. In neuroblasts, Serine180 phosphomutants disrupt the timing of basal polarisation. Serine180 phosphomutants also affect the specification and binary cell fate determination of sensory organ precursors as well as Baz localisation during their asymmetric cell divisions. Finally, we show that CDK1 phosphorylates Serine-S180 and an equivalent Serine on human PAR-3 in vitro.